Lu AF20513

Drug Profile

Lu AF20513

Alternative Names: Anti-Aß vaccine; Anti-beta-amyloid vaccine; LuAF20513

Latest Information Update: 09 Oct 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Lundbeck A/S
  • Class Alzheimer vaccines; Polyclonal antibodies
  • Mechanism of Action Amyloid beta-protein inhibitors; Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I Alzheimer's disease

Most Recent Events

  • 09 Oct 2015 Phase-I clinical trials in Alzheimer's disease in Austria and Finland (Parenteral)
  • 01 Mar 2015 Phase-I clinical trials in Alzheimer's disease in Sweden (Parenteral)
  • 11 Dec 2013 Preclinical trials in Alzheimer's disease in Denmark (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top